Observations and radiative transfer modelling of a massive dense cold core in G333

Cold massive cores are one of the earliest manifestations of high mass star formation. Following the detection of SiO emission from G333.125-0.562, a cold massive core, further investigations of the physics, chemistry and dynamics of this object has been carried out. Mopra and NANTEN2 molecular line profile observations, Australia Telescope Compact Array (ATCA) line and continuum emission maps, and Spitzer 24 and 70 \mum images were obtained. These new data further constrain the properties of this prime example of the very early stages of high mass star formation. A model for the source was constructed and compared directly with the molecular line data using a 3D molecular line transfer code - MOLLIE. The ATCA data reveal that G333.125-0.562 is composed of two sources. One of the sources is responsible for the previously detected molecular outflow and is detected in the Spitzer 24 and 70 \mum band data. Turbulent velocity widths are lower than other more active regions of G333 which reflects the younger evolutionary stage and/or lower mass of this core. The molecular line modelling requires abundances of the CO isotopes that strongly imply heavy depletion due to freeze-out of this species onto dust grains. The principal cloud is cold, moderately turbulent and possesses an outflow which indicates the presence of a central driving source. The secondary source could be an even less evolved object as no apparent associations with continuum emissions at (far-)infrared wavelengths.Comment: 10 pages, accepted to MNRA

The MAST motional Stark effect diagnostic

A motional Stark effect (MSE) diagnostic is now installed and operating routinely on the MAST spherical tokamak, with 35 radial channels, spatial resolution of ∼2.5 cm, and time resolution of ∼1 ms at angular noise levels of ∼0.5°. Conventional (albeit very narrow) interference filters isolate π or σ polarized emission. Avalanche photodiode detectors with digital phase-sensitive detection measure the harmonics of a pair of photoelastic modulators operating at 20 and 23 kHz, and thus the polarization state. The π component is observed to be significantly stronger than σ, in reasonably good agreement with atomic physics calculations, and as a result, almost all channels are now operated on π. Trials with a wide filter that admits the entire Stark pattern (relying on the net polarization of the emission) have demonstrated performance almost as good as the conventional channels. MSE-constrained equilibrium reconstructions can readily be produced between pulses.This work was funded partly by the United Kingdom Engineering and Physical Sciences Research Council under Grant No. P/G003955 and by the European Communities under the contract of association between Euratom and CCFE

Activated Functionalized Carbon Nanotubes and 2D Nanostructured MoS2 Hybrid Electrode Material for High‐Performance Supercapacitor Applications

Alkali-activated functionalized carbon nanotubes (AFCNTs) and 2D nanostructured MoS2 are investigated as a novel hybrid material for energy-storage applications. The nanoflower-like 2D MoS2 is grown on the surface of AFCNT using the controlled one-step hydrothermal technique. The activation of functionalized carbon nanotubes results in greater performance due to the improved surface area. The Brunauer–Emmett–Teller (BET) surface area of the AFCNTs is found to be 594.7 m2 g−1 which is almost 30 times of the as-prepared carbon nanotubes (CNTs). The improved surface area with attached hydroxyl and carboxylic functional groups helps in the attachment of MoS2 nanoflowers onto the AFCNT, thus reducing the interfacial resistance and providing an easy path for electron transfer. The electrochemical analysis shows a high specific capacitance of 516 F g−1 at 0.5 A g−1 with a corresponding energy density of 71.76 Wh kg−1, which is an encouraging reported value from AFCNT and MoS2 hybrid material. To the best of our knowledge, herein, the first report on AFCNTs and 2D MoS2 nanostructured hybrid electrode material for supercapacitor applications is provided, and promising results in terms of specific capacitance, energy density, and power density by boosting the properties of individual material are explained

The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes

Rationale: Chronic obstructive pulmonary disease (COPD) is a phenotypically heterogeneous disease. In COPD, the presence of emphysema is associated with increased mortality and risk of lung cancer. High resolution computed tomography (HRCT) scans are useful in quantifying emphysema but are associated with radiation exposure and high incidence of false positive findings (i.e., nodules). Using a comprehensive biomarker panel, we sought to determine if there was a peripheral blood biomarker signature of emphysema. Methods: 114 plasma biomarkers were measured using a custom assay in 588 individuals enrolled in the COPDGene study. Quantitative emphysema measurements included percent low lung attenuation (%LAA) ≤ −950 HU, ≤ − 910 HU and mean lung attenuation at the 15th percentile on lung attenuation curve (LP15A). Multiple regression analysis was performed to determine plasma biomarkers associated with emphysema independent of covariates age, gender, smoking status, body mass index and FEV1. The findings were subsequently validated using baseline blood samples from a separate cohort of 388 subjects enrolled in the Treatment of Emphysema with a Selective Retinoid Agonist (TESRA) study. Results: Regression analysis identified multiple biomarkers associated with CT-assessed emphysema in COPDGene, including advanced glycosylation end-products receptor (AGER or RAGE, p < 0.001), intercellular adhesion molecule 1 (ICAM, p < 0.001), and chemokine ligand 20 (CCL20, p < 0.001). Validation in the TESRA cohort revealed significant associations with RAGE, ICAM1, and CCL20 with radiologic emphysema (p < 0.001 after meta-analysis). Other biomarkers that were associated with emphysema include CDH1, CDH 13 and SERPINA7, but were not available for validation in the TESRA study. Receiver operating characteristics analysis demonstrated a benefit of adding a biomarker panel to clinical covariates for detecting emphysema, especially in those without severe airflow limitation (AUC 0.85). Conclusions: Our findings, suggest that a panel of blood biomarkers including sRAGE, ICAM1 and CCL20 may serve as a useful surrogate measure of emphysema, and when combined with clinical covariates, may be useful clinically in predicting the presence of emphysema compared to just using covariates alone, especially in those with less severe COPD. Ultimately biomarkers may shed light on disease pathogenesis, providing targets for new treatments. Electronic supplementary material The online version of this article (doi:10.1186/s12931-014-0127-9) contains supplementary material, which is available to authorized users

Experimental Quantum Hamiltonian Learning

Efficiently characterising quantum systems, verifying operations of quantum devices and validating underpinning physical models, are central challenges for the development of quantum technologies and for our continued understanding of foundational physics. Machine-learning enhanced by quantum simulators has been proposed as a route to improve the computational cost of performing these studies. Here we interface two different quantum systems through a classical channel - a silicon-photonics quantum simulator and an electron spin in a diamond nitrogen-vacancy centre - and use the former to learn the latter's Hamiltonian via Bayesian inference. We learn the salient Hamiltonian parameter with an uncertainty of approximately $10^{-5}$. Furthermore, an observed saturation in the learning algorithm suggests deficiencies in the underlying Hamiltonian model, which we exploit to further improve the model itself. We go on to implement an interactive version of the protocol and experimentally show its ability to characterise the operation of the quantum photonic device. This work demonstrates powerful new quantum-enhanced techniques for investigating foundational physical models and characterising quantum technologies

The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes

Abstract Rationale Chronic obstructive pulmonary disease (COPD) is a phenotypically heterogeneous disease. In COPD, the presence of emphysema is associated with increased mortality and risk of lung cancer. High resolution computed tomography (HRCT) scans are useful in quantifying emphysema but are associated with radiation exposure and high incidence of false positive findings (i.e., nodules). Using a comprehensive biomarker panel, we sought to determine if there was a peripheral blood biomarker signature of emphysema. Methods 114 plasma biomarkers were measured using a custom assay in 588 individuals enrolled in the COPDGene study. Quantitative emphysema measurements included percent low lung attenuation (%LAA)≤ - 950 HU, ≤ -910 HU and mean lung attenuation at the 15th percentile on lung attenuation curve (LP15A). Multiple regression analysis was performed to determine plasma biomarkers associated with emphysema independent of covariates age, gender, smoking status, body mass index and FEV1. The findings were subsequently validated using baseline blood samples from a separate cohort of 388 subjects enrolled in the Treatment of Emphysema with a Selective Retinoid Agonist (TESRA) study. Results Regression analysis identified multiple biomarkers associated with CT-assessed emphysema in COPDGene, including advanced glycosylation end-products receptor (AGER or RAGE, p < 0.001), intercellular adhesion molecule 1 (ICAM, p < 0.001), and chemokine ligand 20 (CCL20, p < 0.001). Validation in the TESRA cohort revealed significant associations with RAGE, ICAM1, and CCL20 with radiologic emphysema (p < 0.001 after meta-analysis). Other biomarkers that were associated with emphysema include CDH1, CDH 13 and SERPINA7, but were not available for validation in the TESRA study. Receiver operating characteristics analysis demonstrated a benefit of adding a biomarker panel to clinical covariates for detecting emphysema, especially in those without severe airflow limitation (AUC 0.85). Conclusions Our findings, suggest that a panel of blood biomarkers including sRAGE, ICAM1 and CCL20 may serve as a useful surrogate measure of emphysema, and when combined with clinical covariates, may be useful clinically in predicting the presence of emphysema compared to just using covariates alone, especially in those with less severe COPD. Ultimately biomarkers may shed light on disease pathogenesis, providing targets for new treatments.http://deepblue.lib.umich.edu/bitstream/2027.42/134591/1/12931_2014_Article_127.pd